Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 67%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is poised for strong growth in the coming years, with revised earnings estimates and a significant increase in its net operating income expected through 2026 and 2027. The company's diversified portfolio, particularly its integrated senior health campuses and outpatient medical segments, offers potential for above-average organic growth. With low leverage and a strong balance sheet, American Healthcare REIT is well-positioned to navigate any potential challenges in the healthcare regulatory environment and continue its investment pipeline. While there are some risks, such as potential changes in the healthcare operating environment, the company's strong relationship with operator Trilogy Health Services and its successful track record past track record suggest the potential for continued success.

Bears say

American Healthcare REIT is facing potential headwinds in the future, as its recent $712 million forward equity adds up to over one billion dollars when combined with previous equity issuance and debt assumed through future acquisitions. This aggressive deployment of capital may lead to increased leverage and a potential drag on earnings growth. In addition, the company's focus on medical office buildings and skilled nursing facilities may face challenges in an increasingly competitive market, potentially hindering its ability to generate strong returns for investors.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 67% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Sep 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $61.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $61.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.